Michael A. Blazing
174 works · 15,971 citations · h-index 51
Top works
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes
- Relationship of Depression to Increased Risk of Mortality and Rehospitalization in Patients With Congestive Heart Failure
- Clinical Relevance of C-Reactive Protein During Follow-Up of Patients With Acute Coronary Syndromes in the Aggrastat-to-Zocor Trial
- Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
- Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): Comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes
- Efficacy and Bleeding Complications Among Patients Randomized to Enoxaparin or Unfractionated Heparin for Antithrombin Therapy in Non–ST-Segment Elevation Acute Coronary Syndromes
- Safety and Efficacy of Enoxaparin vs Unfractionated Heparin in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Who Receive Tirofiban and Aspirin A Randomized Controlled Trial
- The incidence and functional consequences of RT-associated cardiac perfusion defects
- Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-IT
- Effects of Early Treatment With Statins on Short-term Clinical Outcomes in Acute Coronary Syndromes
- Expression of the E2F1 transcription factor overcomes type beta transforming growth factor-mediated growth suppression.
- The Benefit of Implementing a Heart Failure Disease Management Program
- The A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapy
- Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia
- Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus
- Prognostic Value of Anxiety and Depression in Patients With Chronic Heart Failure
- Predicting radiotherapy‐induced cardiac perfusion defects
- Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome
- Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention